Cellular and molecular features of asthma mucus plugs provide clues about their formation and persistence

Maude A Liegeois1, Aileen Hsieh2,3, May Al-Fouadi2,3

  • 1Cardiovascular Research Institute, UCSF, San Francisco, California, USA.

Insights

Mucus plugs in fatal asthma stem from acute goblet cell degranulation, while chronic asthma plugs persist due to a persistent airway niche. This research clarifies mucus plug formation and persistence in asthma.

Area of Science:

  • Pulmonology
  • Immunology
  • Cell Biology

Background:

  • Mucus plugs are a hallmark of asthma, contributing to airway obstruction.
  • The precise mechanisms of mucus plug formation and persistence, particularly involving eosinophils, remain incompletely understood.
  • Understanding these processes is crucial for developing targeted therapies for asthma.

Purpose of the Study:

  • To investigate the cellular and molecular characteristics of mucus plugs in asthma.
  • To elucidate the role of airway epithelial cells and eosinophils in mucus plug formation and persistence.
  • To differentiate the features of mucus plugs in fatal versus nonfatal asthma.

Main Methods:

  • Histology and spatial, single-cell proteomics on donor lungs from asthma patients and controls.
  • Airway epithelial cell-eosinophil coculture model to study mucus-induced eosinophil degranulation.
  • Analysis of immune cell infiltration, goblet cell hyperplasia, and mucin composition.

Main Results:

  • Asthma mucus plugs showed innate lymphoid type 2 cells, smooth muscle hyperplasia, and MUC5AC-expressing goblet cells.
  • Immune cells in plugs were often dual-positive for eosinophil peroxidase and neutrophil elastase, suggesting neutrophil-eosinophil interactions.
  • Eosinophils underwent cytolytic degranulation when exposed to mucus from activated airway epithelial cells.
  • Paucigranulocytic plugs (rich in MUC5AC) were more common in fatal asthma, while granulocytic plugs (mixed mucins and DNA traps) predominated in nonfatal asthma.

Conclusions:

  • Fatal asthma mucus plugs likely arise from acute goblet cell degranulation in remodeled airways.
  • Chronic asthma mucus plugs may persist due to a niche involving epithelial cell-mucin-granulocyte crosstalk.
  • These findings offer insights into distinct mechanisms driving mucus plugging in different asthma phenotypes.

Related Concept Videos

Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.6K
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
304
Asthma-I: Introduction01:29

Asthma-I: Introduction

Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.6K
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs01:25

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
206
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
2.7K
Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
174